Barclays maintains Alpha Tau Medical at Overweight, raises PT to $30
Barclays kept Alpha Tau Medical at Overweight and raised its price target to $30.00 per share from $17.00,
Ratings actions GMT) Alpha Tau Medical Price Target Raised to $30.00/Share From $17.00 by BarclaysRatings actions